You are here

BioMarin to Participate in Two Upcoming Investor Conferences

SAN RAFAEL, Calif., Feb. 12, 2020 /PRNewswire/ -- BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) today announced that management will participate in the 9th Annual Leerink Partners Global Healthcare Conference on February 26, 2020 at 10:00am ET in New York City and the Cowen and Company 40th Annual Health Care Conference on March 3, 2020 at 10:40am ET in Boston.  To access the events that are accessible by live webcasts, please visit the investor section of the BioMarin website, A replay will also be archived on the site for at least one week following each event.

About BioMarin

BioMarin is a global biotechnology company that develops and commercializes innovative therapies for people with serious and life-threatening rare disorders. The company's portfolio consists of seven commercialized products and multiple clinical and pre-clinical product candidates.  

For additional information, please visit Information on BioMarin's website is not incorporated by reference into this press release.




Traci McCarty       

Debra Charlesworth

BioMarin Pharmaceutical Inc.  

BioMarin Pharmaceutical Inc.

(415) 455-7558       

(415) 455-7451


Cision View original content to download multimedia:

SOURCE BioMarin Pharmaceutical Inc.